In 2022, South Sudan implemented seasonal malaria chemoprevention (SMC) in Aweil South County, Northern Bahr el Ghazal, targeting 18,000 children 3–59 months. SMC is not commonly utilised in South Sudan due to concerns about sulfadoxine-pyrimethamine (SP) resistance. However, it has been suggested that SMC remains effective, because SP retains its chemoprevention efficacy, even in areas where resistance is high. This study explores community perceptions about the feasibility and acceptability of SMC in South Sudan in order to guide future policy and programme decisions.
This poster was presented at the 72nd annual meeting of the American Society of Tropical Medicine and Hygiene.
Country: South SudanKeywords: ASTMH | Research | Malaria | SMC
« Back to Publications